pI: 9.0783 |
Length (AA): 418 |
MW (Da): 48699 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127827)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_09400 | Protein-tyrosine phosphatase containing protein |
Candida albicans | CaO19.11669 | similar to S. cerevisiae CDC14 (YFR028C) protein phosphatase involved in exit from mitosis |
Candida albicans | CaO19.4192 | similar to S. cerevisiae CDC14 (YFR028C) protein phosphatase involved in exit from mitosis |
Caenorhabditis elegans | CELE_C17G10.4 | Protein CDC-14, isoform C |
Cryptosporidium hominis | Chro.70494 | CDC14 A isoform 2 |
Cryptosporidium parvum | cgd7_4470 | CDC14 phosphatase |
Dictyostelium discoideum | DDB_G0272662 | hypothetical protein |
Drosophila melanogaster | Dmel_CG7134 | CG7134 gene product from transcript CG7134-RD |
Echinococcus granulosus | EgrG_000585900 | dual specificity protein phosphatase CDC14A |
Echinococcus multilocularis | EmuJ_000585900 | dual specificity protein phosphatase CDC14A |
Giardia lamblia | GL50803_9270 | Dual specificity protein phosphatase CDC14A |
Homo sapiens | ENSG00000081377 | cell division cycle 14B |
Homo sapiens | ENSG00000079335 | cell division cycle 14A |
Leishmania braziliensis | LbrM.09.0430 | tyrosine phosphatase, putative |
Leishmania donovani | LdBPK_090470.1 | tyrosine phosphatase, putative |
Leishmania infantum | LinJ.09.0470 | tyrosine phosphatase, putative |
Leishmania major | LmjF.09.0420 | tyrosine phosphatase, putative |
Leishmania mexicana | LmxM.09.0420 | tyrosine phosphatase, putative |
Loa Loa (eye worm) | LOAG_06358 | hypothetical protein |
Mus musculus | ENSMUSG00000033102 | CDC14 cell division cycle 14B |
Mus musculus | ENSMUSG00000033502 | CDC14 cell division cycle 14A |
Neospora caninum | NCLIV_057500 | dual specificity protein phosphatase CDC14A, putative |
Saccharomyces cerevisiae | YFR028C | phosphoprotein phosphatase CDC14 |
Schistosoma japonicum | Sjp_0015270 | ko:K01090 protein phosphatase [EC3.1.3.16], putative |
Schistosoma japonicum | Sjp_0312090 | Dual specificity protein phosphatase CDC14A, putative |
Schistosoma mansoni | Smp_171590 | dual specificity protein phosphatase cdc14 |
Schmidtea mediterranea | mk4.000516.00 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.011425.00 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.002985.00 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.011425.01 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.006312.00 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.021415.00 | Probable tyrosine-protein phosphatase cdc-14 |
Schmidtea mediterranea | mk4.073960.00 | |
Trypanosoma brucei gambiense | Tbg972.11.13900 | tyrosine phosphatase, putative |
Trypanosoma brucei | Tb927.11.12430 | cell division cycle phosphatase 14, putative |
Trypanosoma congolense | TcIL3000_0_20340 | cell division cycle phosphatase 14, putative |
Trypanosoma cruzi | TcCLB.503657.70 | tyrosine phosphatase, putative |
Trypanosoma cruzi | TcCLB.511127.340 | tyrosine phosphatase, putative |
Toxoplasma gondii | TGME49_314430 | serine/threonine specific protein phosphatase |
Trichomonas vaginalis | TVAG_458950 | tyrosine specific protein phosphatase and dual specificity protein phosphatase, putative |
Trichomonas vaginalis | TVAG_362610 | tyrosine specific protein phosphatase and dual specificity protein phosphatase, putative |
Trichomonas vaginalis | TVAG_479730 | dual specificity protein phosphatase CDC14, putative |
Trichomonas vaginalis | TVAG_168700 | dual specificity protein phosphatase CDC-14 alpha, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.4270 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.4270 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.4270 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.4270 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C17G10.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C17G10.4 | Caenorhabditis elegans | slow growth | wormbase |
YFR028C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_314430 | Toxoplasma gondii | Probably non-essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | cell division cycle 14A | Compounds | References |